EP4178440A4 - Kits und verfahren zur messung der insulinempfindlichkeit - Google Patents

Kits und verfahren zur messung der insulinempfindlichkeit Download PDF

Info

Publication number
EP4178440A4
EP4178440A4 EP21838597.9A EP21838597A EP4178440A4 EP 4178440 A4 EP4178440 A4 EP 4178440A4 EP 21838597 A EP21838597 A EP 21838597A EP 4178440 A4 EP4178440 A4 EP 4178440A4
Authority
EP
European Patent Office
Prior art keywords
kits
methods
insulin sensitivity
measuring insulin
measuring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP21838597.9A
Other languages
English (en)
French (fr)
Other versions
EP4178440A1 (de
Inventor
Eric RAVUSSIN
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Louisiana State University
Original Assignee
Louisiana State University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Louisiana State University filed Critical Louisiana State University
Publication of EP4178440A1 publication Critical patent/EP4178440A1/de
Publication of EP4178440A4 publication Critical patent/EP4178440A4/de
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14546—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Optics & Photonics (AREA)
  • Food Science & Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Emergency Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP21838597.9A 2020-07-10 2021-07-12 Kits und verfahren zur messung der insulinempfindlichkeit Pending EP4178440A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063050353P 2020-07-10 2020-07-10
PCT/US2021/041284 WO2022011345A1 (en) 2020-07-10 2021-07-12 Kits and methods for measuring insulin sensativity

Publications (2)

Publication Number Publication Date
EP4178440A1 EP4178440A1 (de) 2023-05-17
EP4178440A4 true EP4178440A4 (de) 2024-10-30

Family

ID=79552128

Family Applications (1)

Application Number Title Priority Date Filing Date
EP21838597.9A Pending EP4178440A4 (de) 2020-07-10 2021-07-12 Kits und verfahren zur messung der insulinempfindlichkeit

Country Status (2)

Country Link
EP (1) EP4178440A4 (de)
WO (1) WO2022011345A1 (de)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5089419A (en) * 1989-08-07 1992-02-18 International Canine Genetics Detection of pregnancy by identification of the c peptide of relaxin in the urine of animals
US20030028125A1 (en) * 2001-08-06 2003-02-06 Yuzhakov Vadim V. Physiological sample collection devices and methods of using the same
US7725148B2 (en) * 2005-09-23 2010-05-25 Medtronic Minimed, Inc. Sensor with layered electrodes
WO2007038670A2 (en) * 2005-09-30 2007-04-05 Perlegen Sciences, Inc. Methods and compositions for screening and treatment of disorders of blood glucose regulation
GB2436873A (en) * 2006-04-07 2007-10-10 Univ Cambridge Tech Blood glucose monitoring systems

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
F RELIMPIO ET AL: "Relationships of C-peptide levels and the C-peptide/bloodsugar ratio with clinical/biochemical variables associated with insulin resistance in orally-treated, well-controlled type 2 diabetic patients", DIABETES RESEARCH AND CLINICAL PRACTICE, vol. 36, no. 3, 1 June 1997 (1997-06-01), NL, pages 173 - 180, XP055126900, ISSN: 0168-8227, DOI: 10.1016/S0168-8227(97)00049-1 *
G�BOR WINKLER ET AL: "Tumor necrosis factor system in insulin resistance in gestational diabetes", DIABETES RESEARCH AND CLINICAL PRACTICE, vol. 56, no. 2, 1 May 2002 (2002-05-01), NL, pages 93 - 99, XP055524804, ISSN: 0168-8227, DOI: 10.1016/S0168-8227(01)00355-2 *
PALIK ET AL: "Elevated serum acylated (biologically active) ghrelin and resistin levels associate with pregnancy-induced weight gain and insulin resistance", DIABETES RESEARCH AND CLINICAL PRACTICE, AMSTERDAM, NL, vol. 76, no. 3, 29 March 2007 (2007-03-29), pages 351 - 357, XP022003401, ISSN: 0168-8227, DOI: 10.1016/J.DIABRES.2006.09.005 *
SAISHO YOSHIFUMI: "Postprandial C-Peptide to Glucose Ratio as a Marker of [beta] Cell Function: Implication for the Management of Type 2 Diabetes", vol. 17, no. 5, 17 May 2016 (2016-05-17), Basel, CH, pages 744, XP093203296, ISSN: 1422-0067, Retrieved from the Internet <URL:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4881566/pdf/ijms-17-00744.pdf> DOI: 10.3390/ijms17050744 *
See also references of WO2022011345A1 *
STEINER J ET AL: "Elevated S100B levels in schizophrenia are associated with insulin resistance", MOLECULAR PSYCHIATRY, NATURE PUBLISHING GROUP UK, LONDON, vol. 15, no. 1, 22 December 2009 (2009-12-22), pages 3 - 4, XP037791370, ISSN: 1359-4184, [retrieved on 20091222], DOI: 10.1038/MP.2009.87 *

Also Published As

Publication number Publication date
EP4178440A1 (de) 2023-05-17
WO2022011345A1 (en) 2022-01-13

Similar Documents

Publication Publication Date Title
EP4305196C0 (de) Verfahren zur messung der fehllokalisierung eines analyten
EP4057562C0 (de) Verfahren und vorrichtung zur messung der konfiguration verschiedener referenzsignale und zellmessberichtsmechanismus
EP4039178C0 (de) Messvorrichtung und verfahren zur messung von änderungen in der chromophorkonzentration
EP3755226C0 (de) System und verfahren zur erkennung und messung affektiver zustände
EP4143590A4 (de) Integrierte messsysteme und verfahren zur synchronen genauen messung von materialeigenschaften
EP3596448A4 (de) Verfahren zur verbesserung der benutzbarkeit und genauigkeit für physiologische messung
EP3922992A4 (de) Kit zur messung eines analyten und verfahren zur bestimmung eines analyten
EP3942568A4 (de) System und verfahren zur automatischen messung evozierter potenziale
EP3526560A4 (de) Vorrichtung und verfahren zur messung der spektren einer flüssigen probe unter verwendung einer integrierenden kavität
EP3623847A4 (de) Pet-vorrichtung mit funktion zur positronenlebensdauermessung und verfahren zur messung der positronenlebensdauer in einer pet-vorrichtung
EP3857235C0 (de) Verfahren zur messung der antikörperdynamik
EP4425181A4 (de) Zusammensetzung zum nachweis oder zur messung eines analyten
EP3891479C0 (de) Verfahren und vorrichtung zur messung der lichtintensität zur abbildung
EP4049920A4 (de) Verfahren zur messung der ebenheit und des abstands von fahrzeugteilen und messtunnel
EP4260027C0 (de) System und verfahren zur messung der farbe eines probenbereichs
EP3805694A4 (de) Verfahren zur messung der flüssigfilmdicke, messvorrichtung, filmherstellungsverfahren
EP4134675A4 (de) Verfahren zur messung der blutgerinnungszeit
EP3835792C0 (de) Beschleunigungsaufnehmer und verfahren zur messung von beschleunigungsdaten
EP4016060A4 (de) Messvorrichtung für optische konstante, verfahren zur messung der optischen konstante und verfahren zur berechnung der optischen konstante
EP4560531A4 (de) Verfahren und vorrichtung zur messung der datenqualität
EP4538654A4 (de) Vorrichtung zur messung physikalischer mengen
EP4215110A4 (de) Verfahren und vorrichtung zur messung der körperzusammensetzung
EP4277335A4 (de) Verfahren und vorrichtung zur messung der strahlqualität
EP3869149C0 (de) Vorrichtung und verfahren zur messung von oberflächen
EP4178440A4 (de) Kits und verfahren zur messung der insulinempfindlichkeit

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20230208

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20240927

RIC1 Information provided on ipc code assigned before grant

Ipc: G01N 33/68 20060101ALI20240923BHEP

Ipc: G01N 33/66 20060101ALI20240923BHEP

Ipc: A61B 5/145 20060101AFI20240923BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20250512